Figure 2
From: EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast

Pure apocrine carcinomas showing HER-2/neu gene amplification (a), EGFR gene amplification (b), polysomy 17 (CEP17) without HER-2/neu gene amplification in a case of an apocrine-like carcinoma (average: 6.06 signals per cell) (c) and polysomy 7 (CEP7) without EGFR gene amplification (average: 3.62 signals per cell) (d).